Skip to main content
CMG Pharmaceutical Co., Ltd. logo

CMG Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 058820 ISIN · KR7058820002 KO Manufacturing
Open in API
Filings indexed 165 across all filing types
Latest filing 2021-12-13 Regulatory Filings
Country KR South Korea
Listing KO 058820

About CMG Pharmaceutical Co., Ltd.

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the development of advanced drug delivery systems. The company's core competency is its Oral Thin Film (OTF), or Orally Dissolving Film (ODF), technology platform. This technology is used to develop improved new drugs, new formulations, and combination therapies designed to enhance patient convenience and efficacy. The company's portfolio includes prescription medications and general pharmaceuticals. As an affiliate of CHA Health Systems, CMG Pharmaceutical is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials.

Recent filings

Filing Released Lang Actions
불성실공시법인지정예고(공시번복)
Regulatory Filings Classification · 100% confidence The document is a formal regulatory notice regarding the designation of a company as an 'unfaithful disclosure corporation' (불성실공시법인) due to a contract cancellation. It cites specific regulatory rules (KOSDAQ market disclosure regulations) and provides details on potential penalties and deadlines. As this is a specific regulatory announcement regarding compliance and disclosure status, it falls under the RNS (Regulatory Filings) category.
2021-12-13 Korean
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the termination of a single sales and supply contract by CMG Pharmaceutical. It details the contract amount, the reason for termination (COVID-19 related delays and business deterioration of the counterparty), and the date of termination. Since this is a specific regulatory disclosure regarding a material business event (contract termination) that does not fit into categories like M&A, financial reports, or share transactions, it is classified as a general regulatory filing.
2021-11-15 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for CMG Pharmaceutical Co., Ltd. for the period ending September 30, 2021. It contains detailed financial statements, business operations, management analysis, and governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) presentation/meeting. It provides the date, time, location (Zoom), and purpose of the event. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2021-10-19 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location (online/conference call), and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into other specific categories like earnings releases or reports, it is classified as a Regulatory Filing (RNS) or a general announcement regarding corporate activities.
2021-10-19 Korean
투자판단관련주요경영사항('Pan TRK 저해 항암신약 CHC2014' 임상 1상 시험 종료)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from CMG Pharmaceutical regarding the completion of a Phase 1 clinical trial for a new drug (CHC2014). It provides specific details on the trial results, regulatory approval dates, and future plans. Since it is a formal disclosure of a material business event (clinical trial results) filed with the regulatory body (KRX), it falls under the 'Regulatory Filings' category as it does not fit into more specific categories like financial reports or dividend announcements.
2021-08-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.